
Predicting risk of disability
Two articles published recently by Australian and international investigators using the MSBase database provide insight into several factors

Two articles published recently by Australian and international investigators using the MSBase database provide insight into several factors

Over the last few years, genetic studies that included thousands of people with MS from around the world

The pharmaceutical sponsor of Gilenya (fingolimod), Novartis, has this week reported one case of Progressive Multifocal Leukoencephalopathy (PML)

Researchers from the University of Virginia in the USA recently discovered a new structure linking the central nervous

Dr George Jelinek and colleagues at the St Vincent’s Hospital Emergency Practice Innovation Centre, Melbourne, have conducted a

A recent study from Italian researchers at the University of Milan has found that certain molecules were present

Associate Professor David Booth, from the Westmead Millennium Institute, has recently concluded his MS Research Australia Senior Research

In order to understand the effect MS has on the brain, researchers need to study the cells, genes,

In addition to the financial support of many individuals and organisations, MS Research Australia relies on a range